Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Bakersfield › NPI 1235772054

Universal Healthcare Services, INC.

Universal Healthcare Services, INC. was paid $2.19M by Medicaid between Jun 2020 and Dec 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.

33Billing provider infoUNIVERSAL HEALTHCARE SERVICES, INC.
BAKERSFIELD, CA 93301
33aNPI1235772054assigned 10/24/2019
33bProvider typeSpecialist
28Total paid$2.19M
24GClaims28,347
24DCodes billed16
24AFirst – last monthJun 2020 – Dec 2024
Compared with peers

Next to other Specialist providers in California

Rank by total paid#105 of 1,230
Median peer was paid$51K
This provider vs. median43×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202052$3K
20211,190$65K
20226,453$347K
20237,812$485K
2024incomplete12,840$1.29M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 49% 14,015 13,687 $1.07M
27096 16% 1,039 545 $349K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 10% 1,709 1,689 $227K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 9.8% 4,274 4,255 $214K
20553 3.0% 787 778 $66K
76881 2.3% 901 890 $51K
76942 2.2% 904 893 $48K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.2% 593 590 $48K
99245 1.5% 176 175 $34K
20610 1.1% 425 289 $25K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.0% 219 219 $23K
99243 <1% 174 174 $16K
4 more codes
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 1,848 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,254 $8K
99244 Office or other outpatient consultation, moderate to high complexity <1% 13 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 16 $450.08

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARMAR, ASHOK (OWNER/PRESIDENT)
Parent organizationUNIVERSAL HEALTHCARE SERVICES, INC.
Same official

Other billing entities under PARMAR, ASHOK

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.